Wolverine Asset Management’s NewAmsterdam Pharma NAMS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4,944
| Closed | -$82.1K | – | 1341 |
|
|
2024
Q3 | $82.1K | Sell |
4,944
-10,580
| -68% | -$176K | ﹤0.01% | 734 |
|
|
2024
Q2 | $298K | Buy |
15,524
+8,394
| +118% | +$161K | ﹤0.01% | 593 |
|
|
2024
Q1 | $169K | Sell |
7,130
-1,564
| -18% | -$37K | ﹤0.01% | 642 |
|
|
2023
Q4 | $97.1K | Buy |
8,694
+5,769
| +197% | +$64.4K | ﹤0.01% | 754 |
|
|
2023
Q3 | $27.1K | Buy |
+2,925
| New | +$27.1K | ﹤0.01% | 939 |
|
|
2023
Q2 | – | Sell |
-4,819
| Closed | -$63.9K | – | 1570 |
|
|
2023
Q1 | $63.9K | Buy |
+4,819
| New | +$63.9K | ﹤0.01% | 859 |
|